After five years behind bars for insider trading, Waksal has announced another biotech deal: His new drug company Kadmon Pharmaceuticals has bought privately held Three Rivers Pharmaceuticals in a private deal estimated at over $100 million.
Continue reading ImClone’s Sam Waksal: Out of Jail and Doing Biotech Deals Again
ImClone’s Sam Waksal: Out of Jail and Doing Biotech Deals Again originally appeared on DailyFinance on Tue, 26 Oct 2010 17:20:00.
Filed Under: Company News, People, Health Care, Eli Lilly